The mitogen-activated protein kinase p38 mediates cellular responses to injurious stress and immune signaling. Among the many p38 isoforms, p38a is the most widely expressed in adult tissues and can be targeted by various pharmacological inhibitors. Here we investigated how p38a activation is linked to cell type-specific outputs in mouse models of cutaneous inflammation. We found that both myeloid and epithelial p38a elicit inflammatory responses, yet p38a signaling in each cell type served distinct inflammatory functions and varied depending on the mode of skin irritation. In addition, myeloid p38a limited acute inflammation via activation of anti-inflammatory gene expression dependent on mitogen-and stress-activated kinases. Our results suggest a dual function for p38a in the regulation of inflammation and show mixed potential for its inhibition as a therapeutic strategy.
The mitogen-activated protein kinase p38 mediates cellular responses to injurious stress and immune signaling. Among the many p38 isoforms, p38a is the most widely expressed in adult tissues and can be targeted by various pharmacological inhibitors. Here we investigated how p38a activation is linked to cell type-specific outputs in mouse models of cutaneous inflammation. We found that both myeloid and epithelial p38a elicit inflammatory responses, yet p38a signaling in each cell type served distinct inflammatory functions and varied depending on the mode of skin irritation. In addition, myeloid p38a limited acute inflammation via activation of anti-inflammatory gene expression dependent on mitogen-and stress-activated kinases. Our results suggest a dual function for p38a in the regulation of inflammation and show mixed potential for its inhibition as a therapeutic strategy.
The inflammatory response is initiated after infection and tissue injury and mobilizes a variety of effector mechanisms that contain and eliminate the causative injurious agent. Cellular and molecular mediators of inflammation also promote tissue repair and regeneration, thus restoring the disturbed tissue organization to a functional state. Although inflammation protects and heals against pathogenic stimuli, it may cause more damage than the inciting event if its magnitude and duration are not strictly controlled by intrinsic negative regulators. Unbalanced and unrestrained inflammatory responses underlie diverse forms of chronic inflammatory diseases regardless of the pathogenic mechanisms involved.
Central to inflammatory signaling is the reversible phosphorylation of protein regulators and effectors by protein kinases and phosphatases. In particular, the distinct mitogen-activated protein kinase (MAPK) pathways mediated by the MAPK family members Erk, Jnk and p38 are pivotal in linking inflammatory stimuli to cellular responses. Mammalian p38 was originally discovered as an evolutionarily conserved protein kinase whose activity is induced by lipopolysaccharide (LPS) and interleukin 1 (IL-1) and also as a protein that binds with high affinity to a group of anti-inflammatory compounds that includes SB202190 (refs. 1-4) . Therefore, its functional relevance to inflammation was predicted at the very outset. In addition to the p38 protein first identified, now called 'p38a' (A001717), three additional paralogs, p38b, p38g and p38d, exist in mammals 5, 6 . Although the four p38 isoforms share a certain degree of structural and enzymatic properties, only p38a and p38b are sensitive to inhibition by SB202190 and its derivatives 7, 8 . The p38a isoform is the most ubiquitously expressed in human and mouse tissues 9 and, in particular, the most abundant in inflammatory cells of myeloid origin 10 .
The MAPK p38 mediates inflammatory responses partly by activating gene expression. Proteins phosphorylated by a mechanism dependent on p38 activity include sequence-specific transcription factors, transcriptional coregulators, nucleosomal proteins and regulators of mRNA stability and translation 11 ; p38 either directly phosphorylates these proteins or induces their phosphorylation by activating other protein kinases called 'MAPK-activated protein kinases' . Those that are phosphorylated by and functionally subordinate to p38 include MK2 and MK3, mitogen-and stress-activated kinase 1 (MSK1; A001562) and MSK2 (A001563), MAPK-interacting kinases 1 and 2, and p38 regulated-activated kinase 11, 12 . MK2 and MK3 can phosphorylate and activate another class of MAPK-activated protein kinases, the p90 ribosomal S6 kinases, albeit specifically in dendritic cells, which demonstrates the multilayered configuration of the protein kinase cascades 'downstream' of p38 (ref. 13 ).
Phosphorylation by p38 and its subordinate kinases induces changes in the activity, turnover and subcellular location of substrate proteins and, consequently, the expression of their target genes.
Attempts to determine how p38a contributes to immunity and inflammatory disease have been hampered by the limited target specificity of p38 inhibitors 14 and early death of p38a-null mouse embryos because of placental and vascular defects [15] [16] [17] [18] . Genedisruption methods that ablate alleles encoding p38a in embryonic but not placental tissues 19 or at postnatal stages in a drug-inducible way 20 permit survival of the mutant mice. However, these p38a-null mice develop spontaneous anomalies in the homeostasis of pulmonary epithelial and fetal hematopoietic tissues, which thus precludes further characterization of their response in experimentally induced diseases. Mice with p38b deficiency have also been generated, but they manifest no discernible altered phenotypes in the inflammation models tested 21 .
In this study, we generated two mouse mutants lacking p38a in different types of cells, myeloid and epithelial, in which p38 probably has distinct functions in inflammation. We subjected these mice with cell type-specific p38a deficiency, which did not show overt tissue disturbances like those of mice with systemic p38a deficiency, to various mechanisms of tissue injury and assessed their inflammatory responses. In both myeloid and epithelial cells, p38a contributed to the onset of inflammation by activating the production of leukocyte chemoattractants and other proinflammatory mediators. We also found that p38a induced the expression of genes encoding antiinflammatory molecules, particularly in myeloid cells such as macrophages, thereby preventing pathology resulting from unrestrained inflammatory responses.
RESULTS

Targeted deletion of p38a
The initiation and progression of inflammation depends on coordinated molecular signaling in both hematopoietic and parenchymal cells. Myeloid cells such as macrophages are among the principal hematopoietic subpopulations serving the inflammatory function. To investigate the cell type-specific functions of p38a in models of cutaneous inflammation, we generated two different mutant mice in which deletion of loxP-flanked alleles of the gene encoding p38a (Mapk14) 22 was mediated by Cre recombinase expressed under the control of the promoter of the myeloid-specific gene encoding lysozyme M (p38a DM mice) or the skin epithelium-specific gene encoding keratin 14 (K14; p38a DK mice) 23, 24 . Both types of the resulting mutant mice ( Supplementary Fig. 1a online) were born alive and grew to adulthood without showing discernible anomalies or developing spontaneous disease in specific pathogen-free conditions (data not shown).
We found highly efficient deletion of Mapk14 ( Supplementary  Fig. 1b ) and a corresponding loss of p38a protein (Fig. 1a) in bone marrow-derived macrophages (BMDMs) prepared from p38a DM mice. Peritoneal exudate macrophages from p38a DM mice injected with thioglycollate showed a similar degree of p38a ablation (data not shown). The yield of p38a DM peritoneal exudate macrophages was similar to that of wild-type p38a peritoneal exudate macrophages (with two loxP-flanked Mapk14 alleles). Wild-type and p38a DM mice also had similar numbers of skin-and spleen-resident cell populations expressing F4/80, a macrophage marker (Fig. 1b) . These results indicate that the recruitment and maintenance of tissue macrophages occur independently of macrophage-autonomous p38a function.
The p38a DK mice had deletion of Mapk14 in the epidermis, as well as in cultured keratinocytes derived from the epidermis, but not in other tissues ( Supplementary Fig. 1c and data not shown). Consistent with those findings, p38a DK epidermis was devoid of detectable p38a protein (Fig. 1c) . The deficiency of p38a in keratinocytes did not interfere with differentiation of the stratified skin epithelium or epidermal-dermal organization (Fig. 1d) ; p38a DK skin expressed wild-type amounts of loricrin, a marker of terminal epidermal differentiation (Fig. 1e) . Ablation of p38a did not perturb expression of the other MAPK proteins, Jnk and Erk (Fig. 1a,c) , or other p38 isoforms ( Supplementary Fig. 2 online) . We also confirmed that Cre expression had no effect on the viability of or inflammatory gene expression in macrophages and keratinocytes ( Supplementary Fig. 3 online and data not shown).
Myeloid p38a in chronic skin inflammation
The absence of spontaneous skin disturbances in p38a DM and p38a DK mice allowed us to analyze the skin pathology that ensues from experimentally induced inflammation. We first used a method to induce chronic skin inflammation by repeated topical treatment with sodium dodecyl sulfate (SDS). Detergent-mediated disruption of epidermal barrier function affects cytokine production, leukocyte infiltration, acanthosis (epidermal hyperplasia) and keratosis 25, 26 . We painted shaved mouse back skin daily with an SDS solution. Wild-type mice began to show skin irritation, as indicated by erythema, within less than 5 d of SDS treatment; it then continued to increase in severity. The inflamed skin had high expression of tumor necrosis factor of macrophage origin; the cells expressing tumor necrosis factor were located in the dermis, and most stained positively for F4/80 (Fig. 2a) .
Next we compared the responses of wild-type and p38a-mutant mice to SDS irritation. Histological analysis of skin tissues from SDStreated wild-type mice showed massive epidermal hyperproliferation and a dermal inflammatory infiltration (Fig. 2b) . These changes were detectable as early as day 4 of treatment and reached their maximum by day 7. The inflammatory response in p38a DK skin was similar in severity and kinetics to that in wild-type skin, as determined by macroscopic and histological examination (Fig. 2b and data not shown), which suggested the dispensability of epithelial p38a in this inflammation model. In contrast, p38a DM mice were highly refractory to topical SDS treatment. No distinct signs of irritation, such as erythema or scaliness, occurred in their skin throughout the course of the treatment. In particular, p38a DM skin tissues were completely devoid of epidermal thickening (Fig. 2b) . Immunofluorescence analysis of SDS-treated skin areas confirmed that the epidermal layer expressing the basal keratinocyte marker K14 was greatly expanded, and we detected cells positive for the proliferation marker Ki67 in wild-type but not p38a DM skin (Fig. 2c) . Infiltration of neutrophils positive for the granulocyte marker Gr-1 was also evident in wild-type skin but was scarce and mild in p38a DM skin (Fig. 2c) . In line with those observations, in SDS-challenged skin tissues, p38a DM mice had much lower expression expressed of transcripts encoding the neutrophilic chemokines KC and MIP-2 (Cxcl1 and Cxcl2, respectively; Fig. 2d ). Lack of myeloid p38a with the resultant dampening of skin inflammation prevented the development of keratotic skin lesions at the end of 7 d of SDS treatment ( Supplementary Fig. 4 online). These results indicate an essential function for myeloid p38a in eliciting cutaneous inflammatory responses and concomitant tissue alterations after SDS-mediated skin barrier disruption.
Involvement of p38a in acute epidermal injury and irritation
To determine whether myeloid and epithelial p38a serve different functions depending on the mode of inflammatory insult, we subjected wild-type and the p38a mutant mice to epidermal injury caused by exposure to ultraviolet B irradiation (UVB). UVB can penetrate only down to the epidermis and thus inflicts primary damage on the skin surface layer. In our test, a single exposure of shaved back skin to UVB resulted in apoptotic death of keratinocytes to a similar degree in wild-type, p38a DM and p38a DK mice (Fig. 3a) . The acute UVB damage was followed by acanthosis and dermal neutrophil infiltration as early as 48 h after exposure in wild-type mice (Fig. 3b) . Deficiency of myeloid p38a did not interfere with the onset of either of these UVB-induced responses ( Fig. 3b and data not shown), which indicated distinct signaling requirements for UVB-and SDS-induced inflammatory responses. UVB-exposed p38a DK skin showed unabated epidermal hyperproliferation but a much lower influx of Gr-1 + neutrophils up to 4 d after irradiation (Fig. 3b) . We confirmed that finding by measuring the activity of myeloperoxidase, a neutrophil marker enzyme, in the skin tissues (Fig. 3c) . The p38a DK mice had much less KC and MIP-2 mRNA in irradiated skin than did wild-type mice (Fig. 3d) ; this finding may have reflected a defect in chemokine gene expression inherent to the keratinocytes. In support of that idea, cultured keratinocytes isolated from p38a DK mice produced much less KC and MIP-2 than wild-type cells did after in vitro UVB exposure (Fig. 3e) . Macroscopically, keratinocyte-specific p38a ablation protected UVB-exposed skin from 'sunburn' injury (focal blistering and erosions), which wild-type and p38a DM skin incurred in less than 2 d after UVB exposure ( Supplementary Fig. 5 online). However, p38a DK mice developed a delayed skin pathology starting on day 5 after irradiation (data not shown). Therefore, unlike in the SDS model, in which myeloid p38a had a dominant proinflammatory function, it was in the keratinocyte that p38a signaling seemed essential for the initiation of inflammation in response to UVB. In addition, UVB-induced acanthosis seemed to occur independently of p38a function in either cell type. Notably, p38a DM skin manifested more severe swelling, indicative of more edema formation, than did wild-type or p38a DK skin after UVB exposure (Fig. 4a,b) . Hence, in UVB-damaged skin, ablation of myeloid p38a not only spared acanthotic and leukocyte chemotactic responses but could even intensify certain aspects of inflammatory pathology. To address whether myeloid p38a negatively regulates vascular permeability and edema formation in other inflammatory settings, we compared acute swelling in the auricle skin of wild-type and p38a DM mice after a single topical application of TPA (12-O-tetradecanoylphorbol-13-acetate). As with UVB-induced damage, TPA irritation-induced edema to a greater extent in 38a DM skin (Fig. 4c,d ). To directly assess the function of myeloid p38a in regulating vascular permeability, we intravenously injected Evans blue, a dye highly adsorbent to serum albumin, into wild-type and p38a DM mice after TPA irritation. The p38a DM mice showed greater extravascular leakage of the injected dye in TPA-treated but not control skin (Fig. 4e) . TPA-treated p38a DM skin also had higher expression of cyclooxygenase 2, a prostaglandin-synthesizing enzyme responsible for triggering various inflammatory symptoms, including vascular hyperpermeability (Fig. 4f) . Therefore, the appreciable function of myeloid p38a in UVB-and TPA-induced skin responses was confined to attenuating, rather than augmenting, inflammatory pathology.
Macrophage gene expression dependent on p38a
The data described so far have shown that both myeloid-and epithelial p38a serve to initiate inflammatory responses depending on the mode of tissue insult. In addition, myeloid p38a exerted negative regulatory effects on certain inflammatory processes. The dual function of myeloid p38a in the coordination of inflammation may be partly attributed to functional diversity of genes whose expression in macrophages is regulated by p38a. We therefore focused our subsequent analyses on identifying the function of p38a in affecting inflammatory gene expression in macrophages.
In an inflammatory milieu, tissue-resident macrophages are exposed to complex p38-activating stimuli that include cytokines, oxidants and products of necrotic cells and invading microbes. For our gene expression analysis, we used lipopolysaccharide (LPS) to activate p38 signaling in cultured macrophages, as its receptor, Toll-like receptor 4, serves as a 'sensor' for the detection of both septic and aseptic injury and is a potent inducer of the transcription of genes encoding inflammatory molecules. We used quantitative real-time PCR to measure the expression of a panel of genes whose induction by LPS was at least fivefold and ranged up to several thousand-fold (data not shown). Of 48 LPS-induced genes analyzed, the expression of 7 genes was much lower in p38a DM BMDMs (36% or lower) than in wild-type BMDMs (Fig. 5a) . These genes showed a similar p38a dependence in peritoneal exudate macrophages ( Supplementary  Fig. 6 online) . We also examined in parallel LPS-induced gene expression in fetal liver-derived macrophages deficient in the kinase IKKb (inhibitor of transcription factor NF-kB (IkB) kinase); these cells are defective in NF-kB-dependent transcription. We found that 77% of the genes tested were IKKb dependent by the same criteria for target gene assignment (Fig. 5a) . Therefore, in contrast to the very broad target spectrum of IKKb-NF-kB signaling, p38a is required for the induction of a relatively restricted number of genes in macrophages. The p38a-dependent genes identified in this screen included Cxcl1 and Cxcl2, the chemokine genes underexpressed in SDS-treated p38a DM skin (Fig. 2d) , and Serpinb2, a reported p38 target gene 27 , as well as Edn1 (encoding endothelin 1), Il10 (encoding IL-10), Mmp13 (encoding matrix metallopeptidase 13) and Vcam1 (encoding the endothelial integrin ligand VCAM-1). We confirmed the function of p38a in mediating LPS-induced expression of these genes by the lower production of their protein products in LPS-treated p38a DM macrophages (Fig. 5b,c) . In particular, the diminished release of IL-10 from p38a-deficient macrophages was accompanied by abrogation of phosphorylation of the transcription factor STAT3 in the cells (Fig. 5d) , an event effected by autocrine IL-10 action 28 .
The inflammatory phenotypes of p38a DM mice may have arisen from lower expression of p38a target genes in macrophages. In particular, the impaired neutrophil recruitment in SDS-treated p38a DM skin (Fig. 2c) could probably be attributed to the defect in macrophage expression of KC and MIP-2. We considered the alternative explanation that ablation of myeloid p38a might have disturbed the chemotactic motility of neutrophils, which expressed the transgene encoding Cre under control of the lysozyme M gene promoter. We ruled out that possibility, however, as neutrophils isolated from wildtype and p38a DM mice showed similar migration in gradients of KC and MIP-2 ( Supplementary Fig. 7 online) . The chemokines were also produced in UVB-exposed keratinocytes by a p38a-dependent mechanism (Fig. 3e) , and this was associated with UVB-induced neutrophil infiltration (Fig. 3b) . Therefore, although distinct inflammatory responses may involve different cellular sources of the chemokines, infiltration of neutrophils in the inflamed tissue seemed to rely on p38a-dependent production of their chemoattractants.
The excessive edema in the UVB-and TPA-challenged skin of p38a DM mice could conceivably have been due to failure of a p38a-mediated anti-inflammatory mechanism. We have identified IL-10, a cytokine with strong anti-inflammatory properties, as a target of myeloid p38a signaling. Of note, studies have shown a crucial function for IL-10 in moderating edema and other inflammatory reactions in chemically irritated and UVB-damaged skin 29, 30 . It has also been shown that removal of myeloid cell-derived IL-10 exacerbates the skin pathology resulting from subcutaneous injection of LPS, but removal of T cell-derived IL-10 does not 31 . Therefore, skinresident macrophages seem to impose restraint on vascular permeability at least partly through p38a-dependent induction of IL-10.
Feedback regulation of p38 by the phosphatase Dusp1
Most inflammatory stimuli that induce p38 activity also trigger other intracellular signaling cascades. We assessed whether p38a deficiency affected the activation of NF-kB, Erk and Jnk in response to LPS and UVB. In both macrophages and keratinocytes challenged by LPS and UVB, respectively, rapid degradation of IkBa and nuclear translocation of the NF-kB proteins RelA and c-Rel occurred independently 
Vcam1 of p38a ( Supplementary Fig. 8 online and data not shown). In contrast, p38a-deficient macrophages showed enhanced and prolonged phosphorylation of Erk and Jnk in response to LPS (Fig. 6a) . Similarly, removal of p38a resulted in constitutive Erk phosphorylation in cultured keratinocytes and resulted in a greater magnitude of Jnk activation in cultured keratinocytes after UVB exposure (Fig. 6b) . These observations are consistent with the function of p38 in antagonizing Erk and Jnk signaling reported before in a variety of cell types 19, [32] [33] [34] [35] . Possible mechanisms linking p38a deficiency and Jnk hyperactivation include inadequate expression or activity of endogenous Jnk inhibitors such as MAPK phosphatases. It has been reported that MAPK phosphatases are sensitive to oxidative inactivation by reactive oxygen species 36 and that p38a acts to counter the accumulation of reactive oxygen species in cells transformed by certain oncogenes 37 . In cultured macrophages, however, p38a deficiency did not lead to higher basal or LPS-induced expression of reactive oxygen species ( Supplementary Fig. 9 online) . However, p38a-deficient macrophages showed much less induction of the protein and mRNA of Dusp1, an MAPK phosphatase that deactivates Jnk and p38 (refs. 38-41; Fig. 6a,c) . Dusp1 was induced only transiently in LPS-stimulated macrophages and thus escaped detection in our screen for p38a target genes whose induction was sustained up to 4 h after LPS treatment (Fig. 5a) . The induction of Dusp1 protein and mRNA in UVBexposed keratinocytes was also highly dependent on p38a (Fig. 6b,d ). Rapid induction of Dusp1 in LPS-and UVB-exposed cells probably contributes to the cross-inhibitory effect of p38a signaling on Jnk activation, although other mechanisms may exist that function in parallel. Furthermore, Dusp1 induction by p38a signaling represents a regulatory loop in which activation of an inflammatory signaling module is restrained by the action of its own output. Failure of this self-limiting mechanism may contribute to hyperinflammatory phenotypes resulting from the absence of p38a, especially in p38a DM mice. Consistent with that idea, loss of Dusp1 was sufficient to accentuate the LPS-induced expression of several but not all p38a target genes in macrophages (Fig. 6e) .
Transcriptional regulation 'downstream' of p38a
Signaling by p38 influences many tiers of gene expression. We first explored whether the lower expression of specific LPS-inducible genes in p38a-deficient macrophages was due to reduced mRNA stability. For this, we incubated LPS-stimulated wild-type and p38a DM macrophages with the RNA synthesis inhibitor actinomycin D and analyzed changes in mRNA abundance over time. None of the p38a target gene transcripts examined showed more rapid decay in p38a DM macrophages ( Supplementary Fig. 10 online) , which suggested that the effect of p38a deficiency on target mRNA expression might instead be attributable to transcriptional mechanisms. In related findings, MSK1 and MSK2 have been shown to relay transcription activation signals from p38 to various components of the transcriptional machinery. We therefore tested the function of the two MSKs in the expression of p38a target genes in BMDMs prepared from mice lacking both MSK1 and MSK2 (double-knockout mice). A subset of the p38a target genes tested was strictly dependent on MSKs for LPS-induced mRNA expression; expression of Il10, Dusp1, Serpinb2 and Edn1 was almost completely abolished or was much lower in the double-knockout cells, whereas expression of the other target genes, Cxcl1, Cxcl2, Mmp13 and Vcam1, was unaffected (Fig. 7a) . These observations indicate that p38a delivers transcriptional activation signals to at least two distinct 'downstream' regulatory modules: MSK-dependent modules and MSK-independent modules.
Among the transcription factors activated through direct phosphorylation by MSKs is CREB 27 . We found CREB-binding sites in the promoter sequences of all MSK-dependent p38a target genes identified (data not shown). Involvement of CREB in the transcriptional activation of Il10, Dusp1 and Serpinb2 has been shown before in the context of LPS-induced gene expression 27, 42, 43 . Induction of CREB phosphorylation in response to LPS and UVB was very robust in wildtype macrophages and keratinocytes but was much weaker or was completely blocked in their p38a-deficient counterparts (Fig. 7b,c) . The residual phosphorylation of CREB in p38a DM macrophages (Fig. 7b) was suppressed by the Erk pathway inhibitor PD98059 (data not shown), which shows a parallel contribution from Erk in LPS-induced CREB activation. The defect in CREB activation in p38a DM macrophages was associated with reduced occupancy of the Il10 and Dusp1 promoters by phosphorylated CREB (Fig. 7d) . It is noteworthy that the genes induced by the p38a-MSK-CREB axis encode extracellular or intracellular regulators with known anti-inflammatory properties. Our gene expression data collectively suggest a dual function for p38a in the regulation of inflammatory gene expression ( Supplementary Fig. 11 online).
DISCUSSION
Here we have analyzed the effect of cell type-specific ablation of p38a on inflammatory responses in mice. Our results have shown that p38a can signal to induce inflammatory gene expression in both myeloid and epithelial cells, such as dermal macrophages and keratinocytes, and can thus provide an initiating cue for local inflammatory reactions from different cellular origins. However, p38a signaling in each cell type served distinct inflammatory functions and varied depending on the nature of tissue injury. For example, myeloid p38a was strictly required for inflammatory infiltration, epidermal hyperproliferation and hyperkeratosis in our model of chronic SDS skin injury. In contrast, acute inflammatory responses to UVBinduced epidermal injury were driven by p38a signaling in keratinocytes, whereas myeloid p38a acted to attenuate UVB-induced vascular hyperpermeability. In all likelihood, stimulus-specific modes of p38a activation determine the cell type in which p38a target genes are first induced and exert their inflammatory function. Our gene expression analysis identified KC and MIP-2 as being induced in both macrophages and keratinocytes by a p38a-dependent mechanism. The impaired production of these neutrophil chemoattractants in macrophages and keratinocytes probably accounts for the diminished infiltration of Gr-1 + cells in p38a DM and p38a DK mice, respectively. Myeloid p38a also signaled to activate anti-inflammatory gene expression. In particular, IL-10 and Dusp1 may mediate the function of myeloid p38a in moderating acute vascular activation in epidermally injured skin. Notably, the p38a-dependent induction of these genes encoding anti-inflammatory molecules relied on the 'downstream' MSK module. Serpinb2, another MSK-dependent p38a target gene, may also mediate the anti-inflammatory regulation exerted by myeloid p38a, as plasminogen activator inhibitor 2 (PAI-2), the product of Serpinb2, inhibits IL-1b secretion in macrophages 44 . A critical function for MSK-dependent gene expression in the negative regulation of inflammation is shown by the hyperinflammatory phenotype of mice lacking both MSK1 and MSK2 (ref. 45) . The divergence of proinflammatory and anti-inflammatory signaling modules in the p38 pathway leaves room for selective targeting of the inflammatory processes governed by each signaling module.
Intracellular signaling pathways that are concurrently activated by the same stimulus often interact with one another through crossregulatory feedback mechanisms. Signaling in such a molecular 'network' constitutes the basis of coordinated cellular responses and, simultaneously, of unanticipated collateral effects of pharmacological signaling modifiers. We found that in both macrophages and keratinocytes, p38a ablation led to enhanced activation of Erk and Jnk. As has been discussed before 13 , the p38a inhibition of Erk activation may involve the suppression of a signaling step 'upstream' of Erk by p90 ribosomal S6 kinases, although this idea remains to be experimentally verified. We believe that p38a-dependent Dusp1 induction in LPSand UVB-exposed cells contributes to the 'switching off' of both Jnk and p38 signaling cascades. In addition, p38a can inactivate the protein kinase complex containing TAK1 (a MAPK kinase kinase acting 'upstream' of both Jnk and p38) through direct phosphorylation of its regulatory subunit, TAK1-binding protein 1 (ref. 33) . Hence, it seems that p38a imposes restraint on Jnk signaling as well as its own activation at many levels.
Pharmacological inhibition of p38 has proven effective in treating or alleviating various inflammatory conditions 5 . However, the toxicity and undesired side effects of p38 inhibitors are recognized as well 46 . The adverse effects of therapy with antibody to p38 may arise from perturbed cross-regulatory signaling or self-limiting mechanisms that rely on p38a activity. In this context, our findings have implications for clinical intervention in the p38 pathway: specific inhibition of a signaling module or a regulatory target that functions 'downstream' of p38a may offer a more efficacious and selective antiinflammatory strategy.
METHODS
Animals.
Mice with loxP-flanked Mapk14 alleles and mice expressing Cre under control of the lysozyme M gene have been described 22, 23 . The p38a DM mice were on a C57BL/6J background, as were their parental strains. After being derived from mice with loxP-flanked Mapk14 alleles and mice expressing Cre under control of the K14 gene promoter 24 , p38a DK mice were crossed into the C57BL/6J background for six generations. All animal studies were according to protocols approved by the Institutional Animal Care and Use Committee.
Primary cell culture. Primary macrophages 47 and keratinocytes 48 were prepared and cultured as described. The extent of Mapk14 deletion and p38a protein absence in each cell preparation was determined by analysis of exon 2 (the loxP-flanked region of the gene) by quantitative real-time PCR and immunoblot analysis, respectively. BMDM preparations from p38a DM mice showed varying degrees of Mapk14 deletion, ranging from 85% to 97%, depending on the duration of differentiation and the cell density of culture batches. Cell preparations with gene deletion of over 95% were used for in vitro studies.
Skin inflammation models. For chronic disruption of the skin barrier, 5% (vol/vol) SDS in PBS was applied to the shaved back skin of mice daily for 7 d. In the model of acute UVB injury, shaved back skin was exposed to UVB (160 mJ/cm 2 ) with UVB bulbs (Southern N.E. Ultraviolet) and a Kodacel filter (Eastman Kodak). The dose of ultraviolet irradiation was monitored with a radiometer (International Light). Skin samples were prepared from SDS-and UVB-challenged mice at various times for histological and molecular analysis. For chemical-induced skin irritation, 2 mg TPA in 20 ml acetone was applied to the right auricle and 20 ml of acetone was applied to the left auricle.
Histology and immunofluorescence. Mouse skin samples were frozen in liquid nitrogen and embedded in optimum cutting temperature medium. Sections 5 mm in thickness were mounted on slides and were stained with hematoxylin and eosin or with antibodies to the following markers: K14 (PRB-155P; Covance), loricrin (PRB-145P; Covance), Gr-1 (553125; BD Pharmingen), F4/80 (MCA497B; Serotec), tumor necrosis factor (557719; BD Pharmigen) or Ki67 (M7249; Dako). Secondary antibodies coupled to Alexa Fluor 488 or Alexa Fluor 594 (Molecular Probes) were used for visualization of primary antibody-bound markers. Sections were counterstained with phalloidintetramethylrhodamine isothiocyanate (Sigma) and with Hoescht stain (Molecular Probes) for visualization of cell bodies and nuclei. The In situ Cell Death Detection kit (Roche) was used for TUNEL staining (TdT-mediated dUTP nick end-labeling).
Myeloperoxidase assay. For analysis of the extent of dermal neutrophil infiltration, skin samples were processed, and the myeloperoxidase activity determined as described 49 .
Measurement of vascular permeability. Evans blue dye (100 ml of a 1% (wt/vol) solution in PBS) was injected intravenously into the lateral tail veins of mice. Auricle samples were photographed 30 min after dye injection. For quantification of extravascular dye content, auricle skin samples were minced, were immersed in formamide at a concentration of 0.5 ml per 100 mg tissue and were incubated for 16 h with vigorous shaking. After removal of debris by centrifugation, the absorbance of the solution was measured at 620 nm.
Protein and RNA analysis. Whole-cell extracts for immunoblot analysis were prepared and analyzed as described 29 . Antibodies to the following were used in immunoblot analysis: Erk (9102) and CREB (9192), and phosphorylated p38 (9211), Jnk (9251) and Erk (9101; all from Cell Signaling Technology); p38a (sc-535), STAT3 (sc-482), phosphorylated STAT3 (sc-8059), RelA (sc-372), c-Rel (sc-71), Dusp1 (sc-1199) and TRAF1 (sc-874; all from Santa Cruz Biotechnology); Jnk (554285; BD Pharmingen); phosphorylated CREB (AF2510; R&D Systems); cyclooxygenase 2 (160126; Cayman Chemical); actin (A4700; Sigma); PAI-2 (a gift from D. Ginsburg); and MMP-13 (a gift from S. Krane). Secreted proteins in culture media were analyzed by enzyme-linked immunosorbent assay (eBioscience) and SearchLight protein array analysis (Pierce). Total RNA was isolated with Trizol (Invitrogen). RNA analysis by quantitative real-time PCR was done as described 29 (primers, Supplementary Table 1 online).
Chromatin immunoprecipitation. Cells were fixed with formaldehyde, then chromatin was isolated and subjected to mechanical shearing and immunoprecipitation as described 50 . Antibody to phosphorylated CREB (R&D Systems) was used for immunoprecipitation of specific chromatin DNA fragments (promoter-specific primers, Supplementary Table 1 ).
Statistical Analysis. P values for a pair of data sets were obtained with the twotailed Student's t-test.
Accession codes. UCSD-Nature Signaling Gateway (http://www.signaling-gate way.org/): A001717, A001562 and A001563.
Note: Supplementary information is available on the Nature Immunology website.
